A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...
Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...
chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.
In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.
Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results